Apellis Set For Blockbuster Success With Syfovre, The First Approved Geographic Atrophy Drug

$2,190 Per Vial Price In Line With VEGF-Based Eye Therapies

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.